Siddharth M. Iyer

SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.

M. Deininger, A. D’Alessandro, J. Reisz, 2021, Blood cancer discovery.

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β Chain Cytokine Receptor Endocytosis.

Kristofer C. Berrett, S. Varambally, J. Radich, 2021, Blood.